Serum FGF19 concentrations in patients with non-cirrhotic PBC were numerically higher, but not statistically different, from levels measured in healthy control subjects (645.6 ± 187.9 vs. 255.9 ± 48.5 pg/ml; p > 0.05) (Fig 1A). Here, FGF19 is linked to primary biliary cholangitis.